Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Results

Q&M posts 23% higher earnings of $8.4 mil for 2Q21; proposes 1-for-5 bonus issue

Atiqah Mokhtar
Atiqah Mokhtar • 2 min read
Q&M posts 23% higher earnings of $8.4 mil for 2Q21; proposes 1-for-5 bonus issue
Q&M is proposing a second interim DPS of 1 cent per share, which follows its 1Q21 interim DPS of the same amount.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Q&M Dental Group has reported earnings of $8.4 million for the 2QFY2021 ended June, translating to a 23% increase y-o-y from $6.8 million previously.

This brings 1HFY2021 earnings to $21.5 million, up 142% y-o-y from $8.9 million previously.

2QFY2021 revenue doubled to $50.8 million from $24.9 million in 2QFY2020, mainly due to higher revenue in dental outlets as well as significant revenue contribution from Covid-19 testing from the group’s Covid-19 medical laboratory business.

1HFY2021 revenue grew 73% y-o-y to $54.7 million.

Excluding the other gains, share of associate loss and one time item, the group’s adjusted earnings for the 2QFY2021 increased more than 10 times to $8.2 million in 2QFY2021.

For 1HFY2021, the group’s adjusted earnings came in at $15 million, up 395% y-o-y.

See also: UOB Kay Hian starts Q&M Dental at 'buy' on twin growth engines and Covid-19 testing business

As at June 30, the group had cash and cash equivalents of $43.9 million, bank borrowing and finance leases of $83.7 million. Net debt was $39.9 million.

Q&M is proposing a second interim dividend of 1 cent per share, which follows its 1QFY2021 interim dividend of 1 cent. The second interim dividend will be paid out on Sep 3.

The group is also proposing a bonus issue of up to 157.5 million new ordinary shares on the basis of one bonus share for every five existing ordinary shares. The bonus issue shares will not be entitled to the second interim dividend.

Commenting on the results, Dr Ng Chin Siau, group CEO of Q&M says, “We will continue to expand organically with a target of opening 30 new clinics yearly starting from 2021 in Singapore and Malaysia. The group is optimistic that our core business would continue to see growth as a result of our expansion efforts, linked to the gradual release of social restrictions, and the subsequent controlled reopening of Singapore. As Singapore shifts to managing Covid-19 as endemic, we see new opportunities to support the government beyond PCR testing, including swabbing and vaccination services.”

For more stories about where the money flows, click here for our Capital section

As at 3.06pm, shares in Q&M are up 2.5 cents or 3.09% higher at 83.5 cents.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.